TNF and ankylosing spondylitis: Synthesis of current evidence from RCTs, data registries, and prospective studies involving the use of anti-TNFα agents for the treatment of inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis suggests an increased risk of serious infections and malignancies.